PFAS Intelligence · November 2026

PFAS Intelligence — November 2026

Treatment completion, industrial agreements and technology policy show different progress, while research distinguishes removal from water from elimination across the wider system.

November 2026PFAS IntelligencePublic briefing · Analytical editionwaterintelligencebrief.com
In this briefing · 01 Key Developments

In this briefing

  1. 01 Key Developments
  2. 02 Technology Spotlight
  3. 03 Investment Tracker
  4. 04 Upcoming Event

Analytical sections are available with Issue purchase or subscription access.

01 Key Developments Free
Drinking-water treatment New Jersey
Salem completes permanent PFAS treatment installation
What's New? New Jersey American Water and Salem City announced completion of a $21.3 million treatment project on October 27. The installation adds granular activated carbon treatment alongside plant modernization, according to the utility's account of the completed works.

Why It Matters: Completion provides a concrete delivery milestone rather than another funding proposal. The utility announcement nevertheless differs from an independent monitoring record, and removal from the treated water does not itself describe the subsequent fate of captured contaminants.

What's Next? Operational monitoring and management of exhausted treatment media remain relevant after construction ends. The service value of a completed installation depends on sustained performance within the plant's operating conditions, rather than on the completion announcement alone.
Water legislation Belgium
Belgium and the Commission commit to implementation
What's New? The European Commission and Belgian regional leaders signed an October 19 statement supporting stronger water-law implementation. The notice includes action on persistent pollutants such as PFAS, alongside more systematic consideration of abstraction and industrial discharge permits.

Why It Matters: Implementation commitments can focus attention on pollution sources as well as treatment. A signed political statement is not the same as a new legal standard, an individual permit decision or verified improvement in environmental water quality.

What's Next? Specific administrative decisions will determine how the commitment translates into practice. Evidence of revised conditions or stronger implementation would be more informative than assuming that a broad statement has already changed every regulated facility's obligations.
Foam fractionation United States
Allonnia reports a federal prototype milestone
What's New? Allonnia's October 20 announcement reports successful completion of a Defense Innovation Unit prototype project for SAFF. The company says the resulting milestone enables follow-on federal contracting without competitive procedures; it does not announce every potential follow-on award.

Why It Matters: Procurement eligibility can change a technology supplier's route to market without proving universal performance. The significance is a completed project and a contracting pathway, distinct from a broad government endorsement of all company claims or applications.

What's Next? Named follow-on contracts and project-specific results would establish the next commercial steps. Eligibility creates an option for purchasers, while actual deployment scope, operating requirements and the treatment of concentrated residuals remain matters for individual projects.
02 Technology Spotlight Free
Integrated treatment Michigan
Concentration coupled with destructive treatment
What It Does: Allonnia describes a separate demonstration at the former Wurtsmith Air Force Base that paired foam fractionation with supercritical water oxidation. The arrangement links removal and concentration with a downstream destruction process rather than treating concentration as the final endpoint.

Why It Matters: A concentrated stream can reduce the volume requiring further treatment while leaving contaminant fate as a separate accounting question. An integrated demonstration is useful because it tests connections between processes that may otherwise be evaluated separately.

Strategic Impact: The commercial proposition extends beyond installing a separation unit toward managing the resulting stream. Its credibility depends on the combined system's documented outcomes, including what enters and leaves each stage, rather than on a removal claim alone.
Industrial treatment Alabama
Industrial UV-based destruction deployment agreement
What It Does: Claros and Daikin announced an October 1 commercial agreement for a full-scale destruction system at Daikin's Decatur manufacturing facility. The planned installation combines the supplier's UV-based treatment platform with analytical testing within a broader facility-improvement program.

Why It Matters: An identified industrial location and commercial agreement define a more concrete application than a general technology claim. They do not independently establish long-term destruction efficiency, regulatory compliance or performance across all possible industrial waste streams.

Strategic Impact: The agreement connects treatment equipment with ongoing measurement, making verification part of the proposed operating service. Commercial significance will depend on delivery and demonstrated results at the facility, not simply on describing the technology as permanent destruction.
03 Investment Tracker Free

Only identified current project milestones are included. The Salem completion and Decatur agreement do not represent comparable quantities of destruction capacity: they concern different water streams, treatment functions and commercial stages. Neither is combined with unrelated modernization expenditure to create a larger PFAS-only investment total.

Salem PFAS treatment installation
October completion announcement covers permanent activated-carbon treatment and plant improvements. The disclosed project value is not a measure of destroyed PFAS, and the utility's broader future investment plans are not added to this individual treatment-project amount.
$21.3 million
Confirmed
Daikin Decatur destruction deployment
October 1 commercial agreement follows earlier collaboration and provides for a full-scale industrial installation. Integration into wider facility improvements remains prospective in the release; agreement execution is not presented as independently verified continuous operation or completed construction.
Not disclosed
Announced
04 Upcoming Event Free
PFAS research exchange United Kingdom
Forever, and Ever, PFAS
London, United Kingdom, March 24, 2027, at the Royal Society of Chemistry, Burlington House. The Environmental Chemistry Group organizes this symposium on PFAS presence and environmental impacts.

Focus: The event centers on environmental chemistry rather than a commercial technology exhibition. Its scientific emphasis offers a setting for examining how PFAS investigations frame environmental questions, without implying endorsement of a particular treatment process or regulatory conclusion.

Features: The organizer plans an extended poster session and networking lunch for researchers to present their work. Speaker updates remain subject to confirmation; the published listing supports the meeting's date and scope, not a finalized speaker roster.
Analytical edition

Continue into the analytical edition

The Analytical Edition examines the boundaries between delivered treatment, residual handling, procurement eligibility and evidence supporting destruction claims.

05

Analysis

Analytical section

PFAS treatment becomes easier to interpret when construction, capture, destruction and authorization are separated. This analysis examines the commercial consequences of those distinctions, explaining why credible progress depends on defining the service and the evidence needed to support it.

06

Policy Watch

Analytical section

Federal technology coordination and Belgian commitments affect different parts of the policy landscape. The distinction is between improving the evidence available for practical choices and strengthening the application of existing obligations, not between competing announcements of a universal treatment requirement.

07

Market Forecast

Analytical section

The outlook differentiates operating treatment assets, industrial destruction deployment and evidence-building initiatives. Each offers observable milestones, but none supports an assumption that all PFAS streams will be addressed through the same process or on the same commercial timetable.

08

Research Spotlight

Analytical section

A biofilm framework and a rural treatment evaluation address different aspects of PFAS evidence. The comparison separates contaminant accounting from site-specific treatment observation, while retaining the limits on what either study can establish beyond its own scope.

09

Final Thoughts

Analytical section

Meaningful progress is visible when the claimed result and the evidence supporting it share the same boundary. The issue closes by distinguishing concrete service delivery from the broader possibilities created by research, agreements and implementation initiatives.

Continue reading

Unlock this Issue

US$39 · One-time purchase

Permanent access to this analytical edition.

Prefer ongoing access? Subscribe from US$29/month · Or choose any 3 Issues for US$89